Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

BACKGROUND: Colorectal cancer liver metastases (CRLM) has not been identified as a unified disease entity due to the differences in the severity of metastatic disease and tumor aggressiveness. A screen for specific prognostic risk subgroups is urgently needed. The current study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jianhong, Li, Weihao, Fan, Wenhua, Zhang, Rongxin, Li, Xinyue, Xiao, Binyi, Dong, Yuejin, Wan, Desen, Pan, Zhizhong, Lin, Junzhong, Wu, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542290/
https://www.ncbi.nlm.nih.gov/pubmed/34688293
http://dx.doi.org/10.1186/s12935-021-02250-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542290/
https://www.ncbi.nlm.nih.gov/pubmed/34688293
http://dx.doi.org/10.1186/s12935-021-02250-x

Ejemplares similares